NDC 0409-1465 – Nalbuphine Hydrochloride

Nalbuphine Hydrochloride 20 mg/mL · Injection, Solution · Intramuscular, Intravenous, Subcutaneous

Human Prescription Drug 1 recall

Product NDC0409-1465

Product details

Brand name
Nalbuphine Hydrochloride
Generic name
Nalbuphine Hydrochloride
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intramuscular, Intravenous, Subcutaneous
Marketing category
ANDA · ANDA070916
Marketed since
December 31, 2004
Listing expires
December 31, 2026
Pharmacologic class
Opioid Agonist/Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Nalbuphine hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
0409-1465-0110 AMPULE in 1 TRAY (0409-1465-01) / 1 mL in 1 AMPULE (0409-1465-71)Dec 31, 2004

Recalls mentioning this NDC

Other Nalbuphine hydrochloride products